Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06171711 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exposure Therapy Study In Adults With Eating Disorders

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Final enrollment: 25 participants (planned 30)
    • Primary completion date changed from estimate of Sep 30, 2026 to Jul 8, 2026
    • Eligibility criteria expanded, about 9 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v14
  3. Primary completion date: Jun 12, 2026 to Sep 30, 2026
    • Study completion date: Jun 30, 2026 to Sep 30, 2026
    • Eligibility criteria revised
    • Site contact updated
    v13
  4. Primary completion date: Jun 30, 2026 to Jun 12, 2026v12
  5. Study description revisedv11
Show 9 earlier versionsHide 9 earlier versions
  1. Enrollment target: 20 to 30v10
  2. Start date: Apr 30, 2024 to May 2, 2024v9
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Sep 14, 2025 to Jun 30, 2026
    • Site details revised
    v8
  4. Start date: Apr 18, 2024 to Apr 30, 2024v7
  5. Start date: Mar 18, 2024 to Apr 18, 2024v6
  6. Start date: Feb 12, 2024 to Mar 18, 2024v5
  7. Start date: Jan 30, 2024 to Feb 12, 2024v4
  8. Start date: Dec 14, 2023 to Jan 30, 2024v3
  9. Study title shortened, about 1 wordv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The current proposal will evaluate the feasibility, acceptability, and preliminary efficacy of Exposure Therapy for anorexia nervosa (AN) spectrum disorders (Exp-AN), an innovative treatment rooted in principles of inhibitory learning. Exp-AN will target anxiety about both eating and weight gain by combining in vivo (i.e., in real life) and imaginal (i.e., mental) exposure in novel ways (e.g., eating a feared food while listening to a recording describing fears about weight gain).
Trial Details
NCT Number NCT06171711
Lead Sponsor Milton S. Hershey Medical Center
Conditions
(from sponsor)		 Eating Disorders, Anorexia Nervosa
Related terms Anorexia Nervosa, Feeding and Eating Disorders
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov